• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种26千道尔顿的酵母DNA拓扑异构酶I片段:晶体结构及机制意义

A 26 kDa yeast DNA topoisomerase I fragment: crystallographic structure and mechanistic implications.

作者信息

Lue N, Sharma A, Mondragón A, Wang J C

机构信息

Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA.

出版信息

Structure. 1995 Dec 15;3(12):1315-22. doi: 10.1016/s0969-2126(01)00269-6.

DOI:10.1016/s0969-2126(01)00269-6
PMID:8747458
Abstract

BACKGROUND

Type I DNA topoisomerases, divided mechanistically into two subfamilies, are ubiquitous enzymes that participate in replication and transcription. In addition to its role in these fundamental processes, the biological importance of eukaryotic DNA topoisomerase I is underscored by its identification as the target of the antitumor alkaloid camptothecin. An understanding of the mechanism of catalysis and interactions with camptothecin and other drugs has been hampered by a lack of detailed structural information.

RESULTS

The three-dimensional structure of a 26 kDA fragment (residues 135 to about 363) of Saccharomyces cerevisiae DNA topoisomerase I has been determined at 1.9 A resolution. The fragment has a novel architecture comprising a concave platform and a pair of outlying V-shaped helices. Photocrosslinking and protein footprinting experiments show that the positively charged concave surface and the junction region of the V-shaped pair of helices contact DNA in the enzyme-DNA complex.

CONCLUSIONS

Crystallographic, biochemical and genetic data indicate that this 26 kDa fragment of yeast DNA topoisomerase I is involved in complex formation between the enzyme and DNA, and probably also in camptothecin-enzyme-DNA ternary complex formation. A molecular model for protein-DNA interaction based on these data is proposed. The bipartite DNA-binding regions of the 26 kDa fragment may enable eukaryotic DNA topoisomerase I to adapt to sequence-dependent structural variations in its DNA substrates.

摘要

背景

I型DNA拓扑异构酶在机制上分为两个亚家族,是参与复制和转录的普遍存在的酶。除了在这些基本过程中的作用外,真核生物DNA拓扑异构酶I作为抗肿瘤生物碱喜树碱的靶点,其生物学重要性也得到了凸显。由于缺乏详细的结构信息,对其催化机制以及与喜树碱和其他药物相互作用的理解受到了阻碍。

结果

酿酒酵母DNA拓扑异构酶I的一个26 kDa片段(残基135至约363)的三维结构已在1.9 Å分辨率下确定。该片段具有一种新颖的结构,包括一个凹面平台和一对外围的V形螺旋。光交联和蛋白质足迹实验表明,带正电荷的凹面以及V形螺旋对的连接区域在酶 - DNA复合物中与DNA接触。

结论

晶体学、生化和遗传学数据表明,酵母DNA拓扑异构酶I的这个26 kDa片段参与了酶与DNA之间的复合物形成,可能还参与了喜树碱 - 酶 - DNA三元复合物的形成。基于这些数据提出了一个蛋白质 - DNA相互作用的分子模型。26 kDa片段的二分DNA结合区域可能使真核生物DNA拓扑异构酶I能够适应其DNA底物中依赖序列的结构变化。

相似文献

1
A 26 kDa yeast DNA topoisomerase I fragment: crystallographic structure and mechanistic implications.一种26千道尔顿的酵母DNA拓扑异构酶I片段:晶体结构及机制意义
Structure. 1995 Dec 15;3(12):1315-22. doi: 10.1016/s0969-2126(01)00269-6.
2
DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.DNA拓扑异构酶I结构域相互作用影响酶活性及对喜树碱的敏感性。
J Biol Chem. 2015 May 8;290(19):12068-78. doi: 10.1074/jbc.M114.635078. Epub 2015 Mar 20.
3
Crystal structure of the amino-terminal fragment of vaccinia virus DNA topoisomerase I at 1.6 A resolution.痘苗病毒DNA拓扑异构酶I氨基末端片段的晶体结构,分辨率为1.6埃。
Structure. 1994 Aug 15;2(8):767-77. doi: 10.1016/s0969-2126(94)00077-8.
4
Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin.酿酒酵母作为研究抗肿瘤药物喜树碱细胞毒性活性的模型系统。
Cancer Chemother Pharmacol. 1994;34 Suppl:S1-5. doi: 10.1007/BF00684856.
5
Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I.
J Biol Chem. 2000 Nov 17;275(46):36181-8. doi: 10.1074/jbc.M006628200.
6
Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.影响人类DNA拓扑异构酶I催化作用和喜树碱敏感性的结构域相互作用。
Mol Pharmacol. 1999 Dec;56(6):1105-15. doi: 10.1124/mol.56.6.1105.
7
Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin.人DNA拓扑异构酶I在缺乏酵母DNA拓扑异构酶I的酵母细胞中的表达:恢复细胞对抗肿瘤药物喜树碱的敏感性。
Cancer Res. 1989 Nov 15;49(22):6318-23.
8
Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality.锁定DNA拓扑异构酶I蛋白夹子会抑制DNA旋转并诱导细胞死亡。
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13767-72. doi: 10.1073/pnas.2235886100. Epub 2003 Oct 29.
9
A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin.人拓扑异构酶I、DNA和喜树碱之间形成的三元可裂解复合物的结构模型。
Biochemistry. 2001 Aug 21;40(33):9792-8. doi: 10.1021/bi010913l.
10
Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin.甘氨酸721的突变改变了DNA拓扑异构酶I的活性位点结构以及对喜树碱的敏感性。
J Biol Chem. 2008 Feb 8;283(6):3305-3315. doi: 10.1074/jbc.M705781200. Epub 2007 Dec 4.

引用本文的文献

1
Dimethylmyricacene: An In Vitro and In Silico Study of a Semisynthetic Non-Camptothecin Derivative Compound, Targeting Human DNA Topoisomerase 1B.二甲基杨梅素:一种半合成非喜树碱衍生物化合物的体外和计算机模拟研究,针对人源 DNA 拓扑异构酶 1B。
Cells. 2022 Nov 3;11(21):3486. doi: 10.3390/cells11213486.
2
An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.对来自动质体原生动物杜氏利什曼原虫的I型DNA拓扑异构酶活性位点的深入了解。
Nucleic Acids Res. 2002 Feb 1;30(3):794-802. doi: 10.1093/nar/30.3.794.